Introduction
Placenta previa develops when the placenta implants in the lower part of the uterus and ends up partially or completely covering the internal opening of the cervix. The condition is caused by early placental placement that occurs too low in the uterine cavity, or by later placental growth that extends downward into an area where it should not remain. In practical biological terms, placenta previa arises when the normal relationship between the implanted placenta and the expanding uterus is disrupted.
The causes are best understood in three broad categories: factors that affect where the embryo implants, factors that alter the uterine lining or shape of the uterus, and factors that change the way the placenta and uterus develop during pregnancy. Several maternal and pregnancy-related risks increase the chance that this low implantation will occur. In many cases, placenta previa is not due to a single cause, but rather to a combination of structural, hormonal, and placental influences.
Biological Mechanisms Behind the Condition
In a normal pregnancy, the fertilized egg travels to the uterus and implants into the endometrium, usually in the upper portion of the uterine cavity. This upper region is favored because it offers a thick, well vascularized lining that supports placental development as the uterus enlarges. As pregnancy continues, the placenta remains attached to the site of implantation, and the lower uterine segment gradually forms below it without interfering with the cervix.
Placenta previa develops when this sequence is altered. The embryo may implant in a lower-than-ideal location, or the placenta may spread across a broader area of the uterine lining in a way that eventually reaches the cervix. The lower uterine segment does not provide the same structural environment as the upper uterus, and once the placenta occupies that space it may partially cover the cervical opening. This becomes clinically important because the cervix must remain closed during pregnancy and then open at delivery. A placenta positioned over or near that opening creates the defining anatomy of placenta previa.
Several physiological mechanisms can contribute to this outcome. One is impaired suitability of the upper uterine lining, often from scarring or inflammation, which makes implantation there less likely. Another is a change in the local signaling between the embryo and endometrium that influences where attachment occurs. A third is abnormal placental enlargement or extension after implantation, especially in pregnancies with larger placental masses or more than one placenta. These mechanisms explain why placenta previa is fundamentally a disorder of implantation and placental positioning rather than a problem that appears late in pregnancy from nowhere.
Primary Causes of Placenta previa
Prior cesarean delivery is one of the strongest associations with placenta previa. A cesarean section leaves a surgical scar in the uterus, most often in the lower segment. Scar tissue differs from normal endometrium: it is less uniform, has altered blood supply, and may not support typical implantation patterns. If a future pregnancy implants near or over this scarred area, the placenta may develop abnormally low. The more cesarean deliveries a person has had, the more likely the uterine environment is to be altered enough to favor low placental implantation.
Other uterine surgery can have a similar effect. Procedures such as dilation and curettage, myomectomy, endometrial surgery, or removal of uterine adhesions can reshape or scar the endometrium. The biologic issue is not the procedure itself, but the tissue remodeling that follows it. Healing may leave patches of fibrosis or areas where the blood supply and glandular structure are different. Since implantation depends on a receptive endometrial surface, these areas may redirect the embryo to a lower segment or encourage placental spread into the lower uterus.
Previous placenta previa also increases risk. This suggests that some individuals have a persistent anatomical or physiological predisposition, such as uterine scarring, placental implantation tendencies, or structural uterine differences. Once the lower uterine segment has supported a placenta in one pregnancy, the same altered environment may influence later pregnancies in a similar direction.
Multiple gestation is another important cause-related factor. Twins or higher-order pregnancies require a larger placental surface area, and in some cases there may be more than one placental disc or a broader shared placenta. A larger placental mass has a greater chance of extending into the lower uterine segment, especially when implantation occurs in a uterus whose upper surface is less favorable. In this sense, the cause is partly mechanical: there is simply more placental tissue that can occupy or approach the cervical region.
Advanced maternal age is associated with placenta previa because uterine and endometrial tissue gradually change over time. With age, the endometrium may show more scarring from prior pregnancies or procedures, altered vascular responsiveness, and changes in implantation receptivity. Older maternal age is therefore less a direct cause than a marker for cumulative uterine exposure and biologic aging of the reproductive tract.
Smoking is another major contributor. Nicotine and other tobacco-related compounds can impair placental development and affect uteroplacental blood flow. Smoking may also alter endometrial receptivity and increase inflammation. These changes can interfere with normal implantation patterns, making low placental placement more likely. The effect appears to involve both vascular disruption and tissue-level changes in the uterine lining.
Contributing Risk Factors
Several additional factors can raise the likelihood of placenta previa even if they are not as strongly linked as prior cesarean delivery. Genetic influences may affect how the endometrium responds to implantation signals, how the placenta invades the uterine lining, and how tissue repair occurs after injury. These inherited tendencies are usually not identifiable by a single gene, but rather reflect differences in placental biology, vascular development, and uterine remodeling.
Hormonal changes can also contribute. Implantation and placental growth depend on a complex interaction of estrogen, progesterone, and locally produced signaling molecules. If these signals are altered, the embryo may implant in a less typical location or the placenta may develop in a way that favors spread toward the lower uterus. Hormonal influences are especially relevant early in pregnancy, when the implantation site is being established.
Environmental exposures may play a role through effects on vascular health and uterine tissue integrity. Exposure to tobacco smoke, air pollutants, or other toxins can increase inflammation and reduce oxygen delivery to the developing placenta. While the evidence varies by exposure, the biological principle is consistent: anything that changes placental attachment, endometrial healing, or uterine blood flow may increase the chance of low implantation.
Infections involving the uterus or cervix may also contribute indirectly. Infection can trigger inflammation, damage the endometrial lining, and leave behind scar tissue after healing. Chronic or recurrent inflammation may alter the local tissue environment enough to affect where implantation occurs. Infections do not usually cause placenta previa on their own, but they can create a receptive surface that is less stable or less suitable for normal placental placement.
Lifestyle factors such as cocaine use, poor overall nutritional status, or high levels of chronic physiological stress may influence vascular tone, placental development, and uterine perfusion. These factors are not specific causes in the way that a uterine scar can be, but they can shift the uterine environment in ways that make low implantation more likely.
How Multiple Factors May Interact
Placenta previa often results from the interaction of several biologic influences rather than one isolated event. A person with a uterine scar from a previous cesarean may already have a lower-quality implantation surface. If that same pregnancy also involves advanced maternal age, smoking, or multiple gestation, the chances of low placental placement increase further. The uterus then receives a combination of structural and functional signals that favor implantation or growth in the lower segment.
These interactions matter because the reproductive system is not governed by a single pathway. Endometrial receptivity, placental invasion, uterine blood flow, and scar healing all influence one another. For example, a scar can alter local blood supply, which can change how the placenta invades and expands. In turn, abnormal placental expansion can place additional stress on surrounding tissue. The final location of the placenta reflects the cumulative effect of these overlapping processes.
In some pregnancies, the placenta may initially implant in a relatively low area and then remain there as the uterus grows. In others, the placenta may implant higher but extend downward as it enlarges. These patterns help explain why placenta previa can appear to develop for different reasons in different individuals even though the final anatomy is the same.
Variations in Causes Between Individuals
The causes of placenta previa differ because each pregnancy begins with a distinct combination of uterine anatomy, reproductive history, and biological environment. One person may have a scarred uterus after several surgeries, while another may have no surgical history but carry twins and develop a large placental surface area. Another may have age-related changes in the endometrium, while someone else may have inflammatory changes from prior infection or heavy smoking exposure.
Genetics can influence how strongly the uterus heals after injury, how the placenta invades, and how the endometrium responds to hormones. Age matters because the cumulative effects of pregnancies, procedures, and tissue remodeling become more pronounced over time. Health status affects vascular function and inflammation, both of which are central to implantation and placental development. Environmental exposure adds another layer by affecting tissue oxygenation, immune signaling, and healing capacity.
This variability is why placenta previa cannot be explained by a single universal pathway. The same final condition may arise from a scarred lower uterine segment in one person, abnormal implantation signaling in another, or a combination of low implantation and placental expansion in a third.
Conditions or Disorders That Can Lead to Placenta previa
Several medical conditions can contribute to placenta previa by altering the uterine lining or the structure of the uterus. Uterine fibroids may distort the shape of the cavity and interfere with where the embryo implants. If fibroids occupy the upper uterus or deform the endometrial surface, implantation may shift lower than usual. The biological effect is mechanical as well as vascular, because fibroids can disrupt blood flow and tissue receptivity.
Endometrial adhesions, also known as intrauterine adhesions or Asherman syndrome, can create areas of scarred or partially obliterated uterine lining. These scars reduce the surface available for normal implantation, making lower segments more likely to be used. Similar logic applies to prior uterine curettage or surgery that leaves patchy endometrial damage.
Congenital uterine anomalies, such as a septate or bicornuate uterus, may alter the geometry of the cavity enough to affect placental placement. If the embryo implants in a narrowed or divided region, the placenta may end up closer to the cervix than it would in a typical uterus. These structural differences change the spatial relationship between the placenta and the cervical opening from the earliest stages of pregnancy.
Placental abnormalities such as a very large placenta or accessory placental lobes can also contribute. When placental tissue is distributed over a broader area, it is more likely to extend into the lower uterine segment. In some cases, abnormal placental morphology reflects the underlying environment of implantation; in others, it is the tissue pattern itself that creates the previa.
Conditions that affect the uterus indirectly, such as chronic inflammation or recurrent infection, may also make placenta previa more likely because they change the tissue environment in which implantation occurs. The common pathway is usually impaired endometrial health and altered placental attachment.
Conclusion
Placenta previa is caused by placental implantation or placental growth in the lower uterus, where it partially or completely covers the cervix. The condition develops through identifiable biological processes, most often involving uterine scarring, altered implantation, abnormal placental expansion, or structural changes in the uterus. Prior cesarean delivery and other uterine surgeries are the strongest contributors because they change the endometrial surface and local blood supply. Multiple gestation, advanced maternal age, smoking, and certain infections or inflammatory conditions can further increase risk by affecting placental development and uterine receptivity.
Understanding the causes of placenta previa requires seeing it as a problem of tissue environment, implantation biology, and placental growth rather than a random pregnancy complication. Different factors can converge on the same final anatomy, and the specific cause in one person may differ from that in another. The key idea is that placenta previa emerges when the normal balance between placental attachment and uterine structure is disturbed, allowing the placenta to occupy the lower uterine segment instead of remaining safely away from the cervix.